A Cancer Rehabilitation Specialist is a healthcare professional who helps cancer patients and survivors regain physical function and improve their quality of life throughout the cancer care continuum. These specialists, often trained in physical or occupational therapy, create customized rehabilitation plans addressing treatment-related side effects such as fatigue, pain, lymphedema, muscle weakness, neuropathy, and mobility challenges. Through therapeutic exercises, manual therapy, and patient education, they assist individuals in restoring strength, endurance, and independence. Their goal is to help patients manage symptoms, reduce disability, and enhance everyday functioning during and after cancer treatment.
Working closely with oncologists, nurses, psychologists, and other members of the care team, Cancer Rehabilitation Specialists provide holistic, patient-centered care. They continuously evaluate progress and modify interventions to meet evolving patient needs. Education on safe physical activity, energy conservation, and adaptive strategies is also a key component of their role. As more people survive cancer, the demand for specialized rehabilitation services is growing, highlighting the vital role these specialists play in supporting recovery. By empowering patients to regain confidence and participate in daily activities, Cancer Rehabilitation Specialists significantly contribute to improving the overall well-being and quality of life of those affected by cancer. Their expertise is essential in helping patients transition smoothly from treatment to survivorship.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China